enzymatically;6 however, technological limitations at the
time did not allow for the synthesis of oligoribonucleotides
using these novel RNA monomers. Furthermore, analo-
gous benzo-expanded analogs of cytidine (3) and uridine
(4) have never been reported. One example of a size-
expanded uridine analog has been reported;7 however,
the glyosidic bond is at the same N1-position as natural
pyrimidine ribonucleosides and is therefore not structurally
analogous to 1 and 2 in a size-expanded RNA genetic set.
Our laboratory has previously reported the design and
synthesis of a set of four size-expanded DNA analogs
(xDNA).8,9 After incorporation into oligonucleotides using
automated oligonucleotide synthesis, these compounds
were studied for their unusual biophysical and biochemical
properties in DNA.10,11 Herein we describe the synthesis of
the complete set of size-expanded RNA analogs (xRNA,
Figure 1) and report their photophysical properties. This
information will provide a foundation on which to design
experiments to use xRNA monomers and polymers in the
study of ribonucleotide and RNA pathways in biological
systems.
approach of using mercuric cyanide as a coupling agent.4
Although both methods are known to form the desired
β-anomers of the nucleosides, they also generate a mixture
of N3- and undesired N1-regioisomers. After chromato-
graphic purification of the N-ribosylated products, an
overall yield of 61% was obtained in a ratio of 60:40
(6a:6b). The correct regioisomer (6a) was identified by
2D-NMR (Supporting Information Figure S1). To obtain
additional amounts of the desired N3-regioisomer, 6b was
converted to 6a via a transisomerization reaction involving
catalytic amounts of p-toluenesulfonic acid.13 Leonard did
not report the overall yield and regioisomeric ratios of their
N-ribosylation reaction, so it is difficult to compare the
€
prior approach to the effectiveness of the present Vorbruggen
approach for generating the rxA precursors. A tandem
O-deacetylation/nucleophilic aromatic substitution reac-
tion of 6a with ammonia generated 1 in good yield. Using
these improved methods, compound 1 can be synthesized
in 5.1% overall yield over 8 steps or 6.0% overall yield in 9
steps (including the transisomerization of 6b).
Scheme 2. Synthesis of rxG Triol (2)
Scheme 1. Synthesis of rxA Triol (1)
The synthesis of rxG, as shown in Scheme 2, has been
previously reported by us as an intermediate in dxG
€
synthesis by reaction of 7 with rib under Vorbruggen
conditions.9 However, the N3- and N1-regioisomeric mix-
ture (8a and 8b, respectively) could only be separated in
later steps. To improve rxG synthesis, we found an eluant
mixture for column chromatography that successfully
separated 8a and 8b. The correct regioisomer (8a) was
identified using 2D-NMR (Figure S1). As was done in rxA
synthesis, we were also able to generate more of the desired
8a regioisomer by transisomerization of 8b. Mild deacyla-
tion by aminolysis of 8a generated 2 in 87% yield. Com-
pound 2 was prepared in 5.0% overall yield over 7 steps or
6.3% overall yield in 8 steps (including the transisomeriza-
tion of 8b).
The synthesesof the expandedpurine nucleosides1 (rxA)
and 2 (rxG) were similar to the syntheses of their xDNA
counterparts, dxA and dxG,8,9 and to previous approaches
to the compounds as reported by Leonard and co-
workers.4,5 The protected xA nucleobase (5, Scheme 1)
was coupled to 1,2,3,5-tetra-O-acetyl-β-D-ribose (rib) under
12
Vorbruggen conditions. This method for forming N-
€
nucleosides is a less hazardous alternative to Leonard’s
(4) Leonard, N. J.; Sprecker, M. A.; Morrice, A. G. J. Am. Chem.
Soc. 1976, 98, 3987.
(5) Keyser, G. E.; Leonard, N. J. J. Org. Chem. 1979, 44, 2989.
(6) (a) Leonard, N. J.; Keyser, G. E. Proc. Natl. Acad. Sci. U.S.A.
1979, 76, 4262. (b) Leonard, N. J.; Scopes, D. I. C.; Van Der Lijn, P.; Barrio,
J. R. Biochemistry 1978, 17, 3677.
(7) Xie, Y.; Maxson, T.; Tor, Y. J. Am. Chem. Soc. 2010, 132, 11896.
(8) Liu, H.; Gao, J.; Maynard, L.; Saito, Y. D.; Kool, E. T. J. Am.
Chem. Soc. 2004, 126, 1102.
The novel expanded pyrimidines 3 (rxC) and 4 (rxU)
were modeled after their xDNA counterparts, dxC and
dxT.8,9 A major structural difference between the xDNA
and xRNA pyrimidine sets is the presence and absence of a
methyl group on the C6 position of their nucleobases,
(9) Liu, H.; Gao, J.; Kool, E. T. J. Org. Chem. 2005, 70, 639.
(10) Gao, J.; Liu, H.; Kool, E. T. J. Am. Chem. Soc. 2004, 126, 11831.
(11) Krueger, A. T.; Kool, E. T. J. Am. Chem. Soc. 2008, 130, 3989.
(13) Boryski, J.; Golankiewicz, B. Nucleosides Nucleotides 1989,
8, 529.
€
€
(12) Vorbruggen, H.; Holfe, G. Chem. Ber. 1981, 114, 1256.
Org. Lett., Vol. 13, No. 4, 2011
677